Barclays raised the firm’s price target on UiPath to $25 from $23 and keeps an Equal Weight rating on the shares. The company continues to show better execution in a stable but dynamic macro environment, the analyst tells investors in a research note. The firm added that revenue outperformance, driven by license strength, and continue discipline on the cost side led to a “healthy” profitability beat.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PATH: